The only FDA-approved prescription eyedrop for acquired ptosis (low-lying lids) that lifts your upper eyelids to open your eyes.

This is the perfect combination product for any eye treatment (eye-lid surgery, laser treatments, thread lifts, fillers, plasma pen, chemical peels, AccuTite, Ultherapy, Renuvion,  etc.).

What is UPNEEQ?

Non-invasive and FDA-approved, Upneeq is a treatment designed to address eyelid ptosis. Instead of utilizing surgery or dermal fillers, Upneeq uses a simple eyedrop prescription to treat eyelid drooping. This method is able to restore a more aesthetically-pleasing smile and upper facial appearance and doesn’t come with any of the risks or recovery time of blepharoplasty. Some studies have shown that patients notice more youthfulness in their face in just minutes to hours after the eyelid drops are applied.

What are the benefits of Upneeq?

  • A safe, FDA-approved, non-surgical procedure
  • Lifts drooping eyelids
  • Revitalizes the face, making it look more youthful and enticing
  • Improves vision by addressing drooping eyelids
  • Eliminates signs of aging
  • The results are noticeable almost immediately
  • There is no downtime or discomfort

How does Upneeq work?

Upneeq was designed to treat acquired blepharoptosis, a condition where the upper lids become weakened and start to droop. Upneeq is an alpha-adrenergic agonist that is formulated with oxymetazoline hydrochloride ophthalmic solution, 0.1%. Oxymetazoline. The primary ingredient in this treatment causes the Muller’s muscle in the upper eyelid to contract, inducing a dramatic lift. Overall, the application of these eyedrops can result in a lift of about 1 to 3 millimeters.

What warnings and precautions are associated with UPNEEQ?

  • Low-lying lids may be related to conditions such as stroke and/or brain aneurysm, Horner syndrome, myasthenia gravis, loss of the ability to move eye muscles, eye infection and eye tumors. Ask your doctor if you have any of these conditions.
  • UPNEEQ is a type of medication that may affect your blood pressure. If you have heart disease, uncontrolled high or low blood pressure, or feel faint at rest or when quickly standing up, you should call your doctor if your symptoms get worse.
  • Patients with reduced blood flow to the brain or heart, or patients who experience eye or mouth dryness due to an immune system disorder (Sjögren’s syndrome) should use care when taking UPNEEQ. Call your doctor immediately if you feel your symptoms may be getting worse.
  • UPNEEQ may increase the risk of eye pressure due to fluid buildup (angle-closure glaucoma) in patients with untreated narrow-angle glaucoma. Call your doctor immediately if you feel increased pressure in your eye after using UPNEEQ.
  • Do not let the tip of the UPNEEQ vial touch your eye or any other surface. This can help prevent eye injury or contamination. Each UPNEEQ vial is for one-time use and should be discarded after being used.